Site navigation

Navigation

Schizophrenia - atypical antipsychotics (replaced by CG82)

The clinical effectiveness and cost effectiveness of newer atypical antipsychotic drugs for schizophrenia

Summary

This guidance has been updated and replaced by CG82 Schizophrenia. NICE has made the following recommendations: Doctors should discuss with the individual which antipsychotic drug to take. The decision about which drugs are prescribed should be made jointly, after the doctor has explained the bene ...

Read the complete summary


Guidance documents

  • No documents found

Implementing this guidance

  • No documents found

About this guidance

Technology appraisals TA43

Issued: June 2002

See related guidance:

See this guidance in practice:

Order printed copies of this guidance